文献速递结核与非结核分枝杆菌

RePORT国际结核病研究联盟叙述性综述:共享多样数据与标本抗击结核病

A Narrative Review of the Regional Prospective Observational Research in Tuberculosis International Consortium: Sharing Diverse Data and Specimens in the Fight Against Tuberculosis.
PubMed 文献 · Clin Infect Dis · 2026-01-01

RePORT International由美国NIAID于2012年创建,采用共同方案在7国招募活动性结核和密切接触者两个队列。

要点

  • 联盟采用共同方案在巴西、印度、印尼、韩国、菲律宾、南非和乌干达招募活动性结核与密切接触者两个队列。
  • 已开展67个国家及联盟层面项目,发表约200篇论文,覆盖流行病学、耐药、生物标志物、诊断和免疫学等。

核心结论

  • RePORT International通过共享多样数据与标本,为结核病预防、诊断和治疗研究提供大规模协调数据支持。

研究设计与样本

  • 叙述性综述,介绍RePORT International联盟的创建背景、组织架构、队列招募、生物样本库和研究成果。
  • 联盟由美国NIAID于2012年创建,采用双边国家资助模式。
  • 7个国家网络使用共同方案招募活动性结核和密切接触者两个参与者队列。
  • 协调中心由多国执行委员会领导,提供早期研究者研究机会、质量保证数据和标本采集指导及科学方向。

主要发现

  • 已通过多个资金来源开展67个国家及联盟层面项目,发表约200篇论文。
  • 研究覆盖流行病学、耐药、生物标志物、合并症、转录组学、诊断和免疫学等领域。
  • 能力建设通过研究奖学金及与其他联盟合作开展,包括公共资源数据库和数据/标本仪表板。

临床怎么用

  • 可利用联盟协调数据集和生物样本库研究结核感染进展、治疗治愈、复发和失败的罕见终点。
  • 可借助联盟平台支持即时诊断、无症状结核筛查、结核后护理和成功治疗结局。

局限性

  • 公共卫生研究在理想患者入组和随访、研究基础设施和人员维护方面存在资金限制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Clinical tuberculosis (TB) research has been hampered by a lack of reliable predictors of Mycobacterium tuberculosis infection progression and active TB treatment's cure, relapse, and failure. Given host and bacterial variability, large sample sizes from harmonized datasets are needed to study infrequent endpoints. Therefore, global observational research consortia, such as Regional Prospective Observational Research in Tuberculosis (RePORT) International (RI), can help make meaningful inroads into successful TB prevention, diagnosis, and treatment. METHODS: RePORT International was created in 2012 by the US National Institute of Allergy and Infectious Diseases (NIAID) with bilateral country funding. The Consortium's country networks (Brazil, India, Indonesia, Korea, Philippines, South Africa, and Uganda) use a common protocol to recruit for 2 participant cohorts (active TB and close contacts). A coordinating center, led by a multinational executive committee, provides early-stage investigator research and mentorship opportunities, guidance on quality-assured data and specimen collection, and scientific direction while allowing networks to pursue geographically relevant research and implementation. RESULTS: Consortium biorepositories house 632 000+ specimens with associated epidemiological data from ∼11 900 participants. There have been 67 country- and consortium-wide projects via multiple funding sources, resulting in about 200 publications covering epidemiology, drug resistance, biomarkers, comorbidities, transcriptomics, diagnostics, and immunology. Capacity building is conducted through research fellowships and collaborations with other consortia including with a public resource database and data/specimen dashboard. CONCLUSIONS: Public health research has had funding limitations on ideal patient enrollment and follow-up, as well as the maintenance of research infrastructure and personnel. However, RI is well prepared to meet these challenges while supporting better point-of-care diagnostics, screening for asymptomatic TB, post-TB care, and successful treatment outcomes.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Bhavaraju R, Andrade B, Siminski S, et al. A Narrative Review of the Regional Prospective Observational Research in Tuberculosis International Consortium: Sharing Diverse Data and Specimens in the Fight Against Tuberculosis. Clin Infect Dis. 2026. PMID: 41974034. doi:10.1093/cid/ciag151

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。